Genmab | Ventes



Sales Changement Date
Agios Pharmaceuticals USD 8.7M 2.03M 2025-03
Almirall EUR 248.42M 382K 2024-06
Amarin USD 42.3M 25.19M 2024-09
Amgen USD 8.15B 936M 2025-03
argenx SE USD 710.24M 38.72M 2025-03
AstraZeneca USD 13.59B 1.3B 2025-03
Bayer EUR 11.73B 1.76B 2024-12
BioMarin Pharmaceutical USD 745M 2.31M 2025-03
Demant DKK 5.62B 40M 2024-12
Exelixis USD 566.76M 27.21M 2024-12
Fresenius Medical Care EUR 4.88B 190M 2025-03
Galapagos EUR 74.98M 870K 2025-03
Genmab DKK 5.28B 59.13B 2025-03
GlaxoSmithKline GBP 7.52B 600M 2025-03
GN Store Nord DKK 3.99B 1.03B 2025-03
GRIFOLS EUR 1.94B 150M 2024-12
Hikma Pharmaceutical USD 1.57B 121M 2024-06
Insmed USD 92.82M 11.62M 2025-03
Lonza CHF 3.06B 580M 2024-06
Merck EUR 5.42B 152M 2024-12
Novartis USD 13.15B 330M 2024-12
Regeneron Pharmaceuticals USD 3.03B 760M 2025-03
Roche Holding CHF 31.64B 883M 2024-12
Sanofi EUR 9.9B 660M 2025-03
UCB EUR 2.79B 127M 2024-06



Genmab Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.